American Journal of Physiology: Renal, Fluid & Electrolyte Physiology (Abstracts) 2016-05-15

BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function.

Wenkuan Xin, Ning Li, Vitor S Fernandes, Biao Chen, Eric S Rovner, Georgi V Petkov

Index: Am. J. Physiol. Renal Physiol. 310 , F994-9, (2016)

Full Text: HTML

Abstract

Large-conductance Ca(2+)-activated K(+) (BK) channels are critical regulators of detrusor smooth muscle (DSM) function. We aimed to investigate phosphodiesterase type 1 (PDE1) interactions with BK channels in human DSM to determine the mechanism by which PDE1 regulates human urinary bladder physiology. A combined electrophysiological, functional, and pharmacological approach was applied using human DSM specimens obtained from open bladder surgeries. The perforated whole cell patch-clamp technique was used to record transient BK currents (TBKCs) and the cell membrane potential in freshly isolated human DSM cells in combination with the selective PDE1 inhibitor, 8-methoxymethyl-3-isobutyl-1-methylxanthine (8MM-IBMX). Isometric DSM tension recordings were used to measure spontaneous phasic and electrical field stimulation-induced contractions in human DSM isolated strips. Selective pharmacological inhibition of PDE1 with 8MM-IBMX (10 μM) increased TBKC activity in human DSM cells, which was abolished by subsequent inhibition of protein kinase A (PKA) with H-89 (10 μM). The stimulatory effect of 8MM-IBMX on TBKCs was reversed upon activation of muscarinic acetylcholine receptors with carbachol (1 μM). 8MM-IBMX (10 μM) hyperpolarized the DSM cell membrane potential, an effect blocked by PKA inhibition. 8MM-IBMX significantly decreased spontaneous phasic and nerve-evoked contractions of human DSM isolated strips. The results reveal a novel mechanism that pharmacological inhibition of PDE1 attenuates human DSM excitability and contractility by activating BK channels via a PKA-dependent mechanism. The data also suggest interactions between PDE1 and muscarinic signaling pathways in human DSM. Inhibition of PDE1 can be a novel therapeutic approach for the treatment of overactive bladder associated with detrusor overactivity. Copyright © 2016 the American Physiological Society.


Related Compounds

Related Articles:

In vivo model with targeted cAMP biosensor reveals changes in receptor-microdomain communication in cardiac disease.

2015-01-01

[Nat. Commun. 6 , 6965, (2015)]

Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta.

1989-10-01

[Biochem. Pharmacol. 38 , 3331, (1989)]

Methylxanthine inhibitors of phosphodiesterases.

1988-01-01

[Meth. Enzymol. 159 , 489, (1988)]

More Articles...